Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
Gongmin Zhu(Chongqing Medical University), Feng Bi(Tianjin University of Traditional Chinese Medicine)
Cited by 461
Related Papers
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
miR‐137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells
|International Journal of Cancer|2010|167
EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy
|Cell Death and Disease|2018|124
Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells
|Oncology Reports|2018|35
Profiles of tumor‑infiltrating immune cells in renal cell carcinoma and their clinical implications
|Oncology Letters|2019|33